Cargando…
Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140803/ https://www.ncbi.nlm.nih.gov/pubmed/34036231 http://dx.doi.org/10.1200/PO.20.00282 |
| _version_ | 1783696248346247168 |
|---|---|
| author | Watanabe, Satomi Takeda, Masayuki Otani, Tomoyuki Yoshida, Takeshi Sakai, Kazuko Olek, Elizabeth Rothenberg, S. Michael Kherani, Jennifer French, Pearl P. Nishio, Kazuto Ito, Akihiko Nakagawa, Kazuhiko |
| author_facet | Watanabe, Satomi Takeda, Masayuki Otani, Tomoyuki Yoshida, Takeshi Sakai, Kazuko Olek, Elizabeth Rothenberg, S. Michael Kherani, Jennifer French, Pearl P. Nishio, Kazuto Ito, Akihiko Nakagawa, Kazuhiko |
| author_sort | Watanabe, Satomi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8140803 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Society of Clinical Oncology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81408032021-05-24 Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer Watanabe, Satomi Takeda, Masayuki Otani, Tomoyuki Yoshida, Takeshi Sakai, Kazuko Olek, Elizabeth Rothenberg, S. Michael Kherani, Jennifer French, Pearl P. Nishio, Kazuto Ito, Akihiko Nakagawa, Kazuhiko JCO Precis Oncol CASE REPORTS American Society of Clinical Oncology 2021-01-11 /pmc/articles/PMC8140803/ /pubmed/34036231 http://dx.doi.org/10.1200/PO.20.00282 Text en © 2021 by American Society of Clinical Oncology https://creativecommons.org/licenses/by/4.0/Creative Commons Attribution Non-Commercial No Derivatives 4.0 License https://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | CASE REPORTS Watanabe, Satomi Takeda, Masayuki Otani, Tomoyuki Yoshida, Takeshi Sakai, Kazuko Olek, Elizabeth Rothenberg, S. Michael Kherani, Jennifer French, Pearl P. Nishio, Kazuto Ito, Akihiko Nakagawa, Kazuhiko Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer |
| title | Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer |
| title_full | Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer |
| title_fullStr | Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer |
| title_full_unstemmed | Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer |
| title_short | Complete Response to Selective RET Inhibition With Selpercatinib (LOXO-292) in a Patient With RET Fusion–Positive Breast Cancer |
| title_sort | complete response to selective ret inhibition with selpercatinib (loxo-292) in a patient with ret fusion–positive breast cancer |
| topic | CASE REPORTS |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140803/ https://www.ncbi.nlm.nih.gov/pubmed/34036231 http://dx.doi.org/10.1200/PO.20.00282 |
| work_keys_str_mv | AT watanabesatomi completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT takedamasayuki completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT otanitomoyuki completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT yoshidatakeshi completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT sakaikazuko completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT olekelizabeth completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT rothenbergsmichael completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT kheranijennifer completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT frenchpearlp completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT nishiokazuto completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT itoakihiko completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer AT nakagawakazuhiko completeresponsetoselectiveretinhibitionwithselpercatinibloxo292inapatientwithretfusionpositivebreastcancer |